Insights from 2023 WCLC
WCLC 2023 Insights: "Osimertinib in Resected EGFRm NSCLC - ADAURA Trial"
By
Insights from 2023 WCLC
FEATURING
Arianna Marinello
By
Insights from 2023 WCLC
FEATURING
Arianna Marinello
Login to view comments.
Click here to Login
